Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kari Mette Toverud | F | - | 6 years | |
Carl Espen Wollebekk | M | 63 |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | - |
Erik Solhjell | M | - |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | - |
Tore Schiøtz | M | 67 |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | - |
Jan Olaf Tønnevold | M | 74 |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | - |
Arnfinn Tveit | M | 81 |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | 16 years |
Torje Tvedt | M | 44 |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | 16 years |
Hans Willy Flisnes | M | - |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | 14 years |
Atle Haga | M | - |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | 21 years |
Øystein Tvenge | M | 69 |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | - |
Birgitte Engebretsen | F | 52 |
Hiddn Security AS
Hiddn Security AS Computer PeripheralsElectronic Technology Hiddn Security AS engages in the provision of encryption solutions. It develops, manufactures, and markets hardware-based encryption, authentication, and digital content security products. The company was founded in 1998 and is headquartered in Oslo, Norway. | - |
André Johannessen | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Henno Grenness | M | - | 4 years | |
David Solomon | M | 63 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 1 years |
Anker Gunvald Lundemose | M | 63 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 2 years |
Soren Keller | M | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Geir Johansen | M | - | 3 years | |
Benedicte Fossum | F | 62 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 4 years |
Helene Jebsen Anker | F | 65 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Ingrid Elvira Leisner | F | 55 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Per Thoresen | M | 71 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Kim-André Evensen | M | - | 3 years | |
Hilde Hermansen Steineger | M | 58 |
University of Oslo
| 3 years |
Thomas Hofstaetter | M | 76 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 1 years |
Jerome Zeldis | M | 74 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 4 years |
Rich Eilif Larsen | M | - | 7 years | |
Jørgen Fischer Ravn | M | 55 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 1 years |
Kirsten Drejer | M | 68 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 1 years |
Trygve Burchardt | M | - |
University of Oslo
| 8 years |
Steen Kroyer | M | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Hege Schøyen Dillner | F | 57 |
University of Oslo
| 1 years |
Stephan Michal Wold Eide | M | 55 |
University of Oslo
| 3 years |
Robin Bakken | M | 48 |
University of Oslo
| 3 years |
Hans Ola Haavelsrud | M | - | - | |
Barbara A. Ruskin | M | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 1 years |
Kamilla Rolsted | M | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 1 years |
Nils Gram | M | - | - | |
Jens Krois | M | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 1 years |
Inger Grete Lundemo | M | 51 |
University of Oslo
| 1 years |
Håvard Vikse | M | - |
University of Oslo
| 4 years |
Jens Bjørheim | M | - |
University of Oslo
| 3 years |
Tore Sande | M | 55 |
University of Oslo
| 3 years |
Andreas Martinussen | M | 40 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Simen Thorsen | M | 47 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Tarjei Røise Warholm | M | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Sindre Svendsen Østgård | M | - |
University of Oslo
| 2 years |
Sofia Katarina Finneng | F | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Mona Lynne Eitzen | F | 49 | - | |
Bente Bøhler | M | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Felix Reimers | M | - |
University of Oslo
| 3 years |
Marianne Langrind Kvanvik | F | 50 |
University of Oslo
| 3 years |
Viktor Sigurd Wold Eide | M | 53 |
University of Oslo
| 1 years |
Adele Bugge Norman Pran | F | 54 |
University of Oslo
| 3 years |
Bernd Seizinger | M | 67 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Tore Aksel Voldberg | M | 61 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Håvard Hildeng Hauge | M | 55 |
University of Oslo
| 3 years |
Russell Greig | M | 71 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 1 years |
Christen Krogh | M | - |
University of Oslo
| 3 years |
Norbert Hoyer | M | - |
University of Oslo
| 3 years |
Ole Dahlberg | M | - |
University of Oslo
| 1 years |
Anne Kjølseth | F | - |
University of Oslo
| 4 years |
Iacob Mathiesen | M | 57 |
University of Oslo
| 3 years |
Edith Rian | M | 58 |
University of Oslo
| 3 years |
Henrik Inadomi | M | - |
University of Oslo
| 4 years |
Synne Hermansen Røine | F | 45 |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | 2 years |
Giuditta Cordero-Moss | M | 61 |
University of Oslo
| 3 years |
Benedicte Teigen Gude | F | 53 |
University of Oslo
| 1 years |
Christopher William Ihlen | M | 56 |
University of Oslo
| 6 years |
Martin Nes | M | 55 |
University of Oslo
| 3 years |
Erik Helstad | M | 57 |
University of Oslo
| 3 years |
May Arna Risberg | M | - |
University of Oslo
| 3 years |
Børge Grøttjord | M | - |
University of Oslo
| 3 years |
Jostein Dahle | M | 51 |
University of Oslo
| 3 years |
Unni Hjelmaas | F | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | - |
Wenche Margaretha Seljeseth | F | 60 |
University of Oslo
| 3 years |
Bjørn Næss | M | - |
University of Oslo
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Norway | 74 | 97.37% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cecilie Grue
- Personal Network